Panbela Therapeutics, Inc. Common Stock ($0.001 par value per share) Sales AgreementSales Agreement • July 20th, 2022 • Panbela Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 20th, 2022 Company Industry JurisdictionPanbela Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Roth Capital Partners, LLC (the “Agent”), as follows: